logo
Select company
Select metric
-353.22%Return on Equity
VS
Market
4
Sector
11
Industry
13
History
34
$ 14.7Close
$ 5.55 - $ 772.5 52-Week Range
Ticker Information

Ticker

HSDT

Company Name

HELIUS MEDICAL TECHNOLOGIES INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

HELIUS MEDICAL TECHNOLOGIES INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HSDT - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 6.03M$ -21.29M-353.22%
3/31/2025$ 1.28M$ -13.06M-1020.62%
12/31/2024$ 1.06M$ -11.74M-1108.78%
9/30/2024$ 3.8M$ -8.86M-233.19%
6/30/2024$ 6.34M$ -8.84M-139.39%
3/31/2024$ 1.99M$ -8.87M-446.73%
12/31/2023$ 2.35M$ -8.85M-376.6%
9/30/2023$ 3.02M$ -12.69M-420.09%
6/30/2023$ 4.57M$ -10.06M-219.99%
3/31/2023$ 6.07M$ -12.22M-201.42%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HELIUS MEDICAL TECHNOLOGIES INC's latest trailing twelve months (TTM) ROE stands at -529.43%.
  • Over the past 5 years, HELIUS MEDICAL TECHNOLOGIES INC's average ROE has been -355.73%.
  • The median ROE for HELIUS MEDICAL TECHNOLOGIES INC during this period was -298.49%
  • HELIUS MEDICAL TECHNOLOGIES INC reached its highest ROE over the past 5 years at -102.52%.
  • The lowest ROE recorded by HELIUS MEDICAL TECHNOLOGIES INC in the same timeframe -1108.78%

HELIUS MEDICAL TECHNOLOGIES INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
MOVE : MOVANO INC -1235.19%TIVC : TIVIC HEALTH SYSTEMS INC -171.98%STSS : SHARPS TECHNOLOGY INC -4.97%AMIX : AUTONOMIX MEDICAL INC -171.32%AIM : AIM IMMUNOTECH INC -HSCS : HEARTSCIENCES INC -279.15%BBLG : BONE BIOLOGICS CORP -112.69%HCWB : HCW BIOLOGICS INC -SILO : SILO PHARMA INC -99.55%VTAK : CATHETER PRECISION INC -354.4%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for HELIUS MEDICAL TECHNOLOGIES INC is calculated as follows: Net Inc. Cmn. [ $ -16.93M ] / Equity [ $ 3.2M ]
(=) ROE [ -529.43% ]

HSDT - Return on Equity, Last 5 years

-1108.78%

Minimum

Dec 31, 2024

-102.52%

Maximum

Sep 30, 2022

-355.73%

Average

-298.49%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%